PILA — Pila Pharma AB Share Price
0.000.00%
Last trade - 00:00- SEK66.62m
- SEK61.44m
- SEK1.46m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 10 | ||
| Price to Tang. Book | 14.78 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 45.54 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -148.48% | ||
| Return on Equity | -122.66% | ||
| Operating Margin | -675.99% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 0.35 | n/a | 0.72 | 1.88 | 1.46 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pila Pharma AB is a Sweden-based clinical stage pharmaceutical company, active in the biotechnology sector. The Company conducts clinical tests in phase 2 with drugs against type 2 diabetes. The target product is a tablet that is taken orally in an early stage of diabetes to restore the body's insulin production and thereby reduce the patient's blood sugar level. PILA PHARMA's patent-protected product candidate is called XEN-D0501 and is a TRPV1 antagonist, a novel type of oral anti-diabetic agent for treatment of type 2 diabetes. Pila Pharma AB has completed two phase 2a clinical trials (PP-CT01 and PP-CT02), that both demonstrated that XEN-D0501 is well tolerated by people with type 2 diabetes. In addition, the product is expected to have fewer unwanted side effects than alternative forms of treatment.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 26th, 2014
- Public Since
- July 15th, 2021
- No. of Employees
- 1
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 23,793,289
- Address
- Vastergatan 1, MALMO, 211 21
- Web
- https://pilapharma.com/
- Phone
- Auditors
- Deloitte & Touche AB
Upcoming Events for PILA
Similar to PILA
Biogaia AB
OMX Nordic Exchange Stockholm
BoneSupport Holding AB
OMX Nordic Exchange Stockholm
Calliditas Therapeutics AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cline Scientific AB
OMX Nordic Exchange Stockholm
FAQ
What is the Pila Pharma AB share price?
As of Today at 22:39 UTC, shares in Pila Pharma AB are trading at SEK2.80. This share price information is delayed by 15 minutes.
How has the Pila Pharma AB share price performed this year?
Shares in Pila Pharma AB last closed at SEK2.80 and the price had moved by -5.41% over the past 365 days. In terms of relative price strength the Pila Pharma AB share price has underperformed the FTSE Global All Cap Index by -16.05% over the past year.
What are the analyst and broker recommendations for Pila Pharma AB?
There is no consensus recommendation for this security.
What is the Pila Pharma AB dividend yield?
Pila Pharma AB does not currently pay a dividend.
Does Pila Pharma AB pay a dividend?
Pila Pharma AB does not currently pay a dividend.
When does Pila Pharma AB next pay dividends?
Pila Pharma AB does not currently pay a dividend.
How do I buy Pila Pharma AB shares?
To buy shares in Pila Pharma AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Pila Pharma AB?
As of the previous close price of SEK2.80, shares in Pila Pharma AB had a market capitalisation of SEK66.62m.
Where are Pila Pharma AB shares listed?
Here are the trading details for Pila Pharma AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: PILA
What kind of share is Pila Pharma AB?
Based on an overall assessment of its quality, value and momentum Pila Pharma AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Pila Pharma AB share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Pila Pharma AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pila Pharma AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +67.52%.
As of the last closing price of SEK2.80, shares in Pila Pharma AB were trading +54.92% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Pila Pharma AB PE Ratio?
The Pila Pharma AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK2.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Pila Pharma AB?
We do not have data on Pila Pharma AB's directors